Health
Using peanuts to cure potentially deadly allergy
Publish Date: Jan 30, 2014
Using peanuts to cure potentially deadly allergy
Peanut allergy affects about one in fifty children
  • mail
  • img
newvision

PARIS - Doctors said Thursday they could treat peanut allergy by feeding children the very thing their bodies reject, so building tolerance that could save a life in case of accidental ingestion.

Small doses of peanut powder taken over several months seemed to induce tolerance in children with the potentially deadly allergy, a research team wrote Wednesday in The Lancet medical journal.

After six months of treatment, dubbed oral immunotherapy or OIT, 84-91 percent of the children in a trial could safely tolerate daily doses of 800 mg (0.03 ounces) of peanut powder -- the equivalent of about five peanuts, wrote the team.

This was 25 times the amount they could tolerate before the therapy, and much larger than any accidental dose is likely to ever be.

"The treatment allowed children with all severities of peanut allergy to eat large quantities of peanuts, well above the levels found in contaminated snacks and meals, freeing them and their parents from the fear of a potentially life threatening allergic reaction," said study leader Andrew Clark from Cambridge University Hospitals.

"The families involved in this study say that it has changed their lives dramatically."

The trial involved 99 allergic children aged seven to sixteen.

One in five of the kids receiving OIT reported "adverse events" -- mostly mild itching of the mouth, the authors said.

They stressed that people should not try the treatment at home as more research was needed.

Peanut allergy affects about one in fifty children and is the most common cause of fatal food allergy reactions, said a press statement. About 10 million people around the world are allergic to peanuts.

Symptoms vary from mild to severe, from swollen lips or shortness of breath to anaphylactic shock, which can be fatal.

While "exceptionally promising", the method remains experimental, Matthew Greenhawt from the University of Michigan Food Allergy Center wrote in a comment also carried by The Lancet.

"It is unknown if OIT can produce lasting tolerance," he wrote.

AFP

The statements, comments, or opinions expressed through the use of New Vision Online are those of their respective authors, who are solely responsible for them, and do not necessarily represent the views held by the staff and management of New Vision Online.

New Vision Online reserves the right to moderate, publish or delete a post without warning or consultation with the author.Find out why we moderate comments. For any questions please contact digital@newvision.co.ug

  • mail
  • img
blog comments powered by Disqus
Also In This Section
Gov’t on the spot over absence at PEPFAR meeting
Government is on the spot over why Uganda was the only country not represented at the regional US PEPFAR review meeting....
District compensates family of dead patient
Nakaseke district adheres to court decision that ordered it to pay sh35m as compensation to David Mugerwa who lost his wife due to negligent acts....
Economist seeks sh115m for kidney transplant
53-year-old Bernard Tayebwa is appealing to philanthropists for sh115m, to undergo a kidney transplant in India....
Ugandan women with HIV
Ugandan women with HIV who are not on treatment die faster than their male counterparts, according to a new study....
Ethiopia implements smoking ban
The bars and cafes are full and lively in the northern town of Mekelle - but they are no longer smoke-filled....
Making painkillers from yeast
A team of US scientists say they have taken an important step toward engineering painkillers from yeast....
Do you support KCCA'S move to ban campaign posters from the city?
Yes
No
Can't Say
follow us
subscribe to our news letter